Astromech, Colossal Spinout, Raises $20M at $3.8B Valuation

Astromech, a spinout of Colossal Biosciences valued at $12B, has raised $20M at a $3.8B valuation. The company focuses on AI-assisted drug design and discovery, led by founder and CEO Ben Lamm.

2026-08-21 ~ 2026-08-21 · 2 related posts

• Colossal spinout Astromech raises $20M at $3.8B valuation as AI biotech heats up — MaxUnfried · 2026-08-21
• Colossal Spinoff Astromech Raises $20M as AI Biotech Explodes — anselm · 2026-08-21